Current Drug Targets
Title:Editorial: New Potential Targets for the Treatment of Biliary Diseases
Volume: 18 Issue: 8
Author(s): Jesus M. Banales*
Affiliation:
- Head, Liver Diseases Group Biodonostia Research Institute-Donostia University Hospital- Assistant Professor of Medicine/Sciences University of Navarra,United States
Export Options
About this article
Cite this article as:
Banales M. Jesus*, Editorial: New Potential Targets for the Treatment of Biliary Diseases, Current Drug Targets 2017; 18 (8) . https://dx.doi.org/10.2174/138945011808170504184900
DOI https://dx.doi.org/10.2174/138945011808170504184900 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
28
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Peroxisome Proliferator-Activated Receptor Science
Current Medicinal Chemistry PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Therapeutic Potential of Perineural Invasion, Hypoxia and Desmoplasia in Pancreatic Cancer
Current Pharmaceutical Design Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer
Current Cancer Drug Targets Overview of Current Immunotherapies Targeting Mutated KRAS Cancers
Current Topics in Medicinal Chemistry Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D
Current Pharmaceutical Biotechnology Onco-Surgical Management of Colo-Rectal Liver Metastases in Older Patients: A New Frontier in the 3<sup>rd</sup> Millennium
Anti-Cancer Agents in Medicinal Chemistry An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science Novel Protein Targeted Therapy of Metastatic Melanoma
Current Pharmaceutical Design Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular Targets for Therapy of Hematological Malignancies
Current Molecular Medicine The Influence of Macrophages and the Tumor Microenvironment on Natural Killer Cells
Current Molecular Medicine Solubilization and Antitumor Activity of Oleanolic Acid Lysinate
Current Analytical Chemistry Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Unknown Primary Squamous Cell Carcinoma of the Head and Neck
Current Cancer Therapy Reviews Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Focal Adhesion Kinase: From In Vitro Studies to Functional Analyses In Vivo
Current Protein & Peptide Science Assessment of Cell Cytotoxicity and Comet Assay on HER2/neu Positive Cell Line Due to <sup>111</sup>In Auger Electrons as DNA-Targeting Radioimmunoconjugate
Current Radiopharmaceuticals Pain Biomarkers in Cancer: An Overview
Current Pharmaceutical Design HCV-Related Transformation and New Therapeutic Strategies: An Update
Current Cancer Therapy Reviews Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers
Current Medicinal Chemistry